A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease

Grant

Date/time Interval

  • March 30, 2018 - March 29, 2020
  • Total Award Amount

  • 86420.00
  • Direct Costs

  • 66477.00
  • Sponsor Award Id

  • Contributor

  • Acosta Lara, Maria   Investigator  
  • Danila MD, MSc, MSPH, Maria   Investigator  
  • Duncan, Steven   Principal Investigator  
  • Gulati, Swati   Investigator  
  • Kulkarni, Tejaswini   Investigator  
  • Luckhardt, Tracy   Investigator